Tue, 10 Feb 2015 | BUSINESS SALE
Outsourcing Giant Capita has acquired an engineering design practice based in Leeds.
BCS Design is a provider of services in civil, structural and geotechnical engineering as well as surveying for the transport and industrial industries. The firm will now join with Capita and its property and infrastructure operation.
Chris Silverwood of Ethos Corporate Finance led the deal, alongside a number of advisers including KPMG's Chris Stott who headed up the team dealing with the seller's due diligence.
BCS Design was set up in 2003 by civil engineer and managing director Steve Osbaldeston. Martin Cure later joined him as a shareholder and director, and both will retain their positions in the firm as part of the takeover.
Osbaldeston said of the acquisition: “Working as part of a major consultancy will allow us to invest in the future growth of our business, further develop our staff, and target larger projects and programmes – as well as giving our clients access to the skills and transformational expertise of a market-leading business.”
Capita Property & Infrastructure executive director Simon Birchall added that the acquisition proved an ideal fit for the business.
He explained: “It reflects our commitment to growth both organically and through the acquisition of strong and innovative businesses that expand our existing teams and provide the best solutions for our clients.”
______________________________________________________________________
Related information:
How to achieve the highest return when selling your business
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.